Cargando…
SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300317/ https://www.ncbi.nlm.nih.gov/pubmed/32595541 http://dx.doi.org/10.3389/fpsyt.2020.00550 |
_version_ | 1783547563769593856 |
---|---|
author | Kreuzer, Peter M. Baghai, Thomas C. Rupprecht, Rainer Wittmann, Markus Steffling, Dagmar Ziereis, Michael Zowe, Marc Hausner, Helmut Langguth, Berthold |
author_facet | Kreuzer, Peter M. Baghai, Thomas C. Rupprecht, Rainer Wittmann, Markus Steffling, Dagmar Ziereis, Michael Zowe, Marc Hausner, Helmut Langguth, Berthold |
author_sort | Kreuzer, Peter M. |
collection | PubMed |
description | The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are extremely present both for individuals and societies as a whole. In this manuscript, we aim to exemplarily describe the bullet points concerning (a) the internal risk management, (b) the organizational and structural changes, and (c) the communicational strategies applied in a Psychiatric University Hospital in the Southern part of Germany. The authors are well aware about the fact that almost none of these considerations may be considered as evidence-based at the moment. However, the authors trust that these reflections and experiences may be useful as an orientation for similar risk constellations in other afflicted countries due to the temporal delay of the pandemic course. |
format | Online Article Text |
id | pubmed-7300317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73003172020-06-26 SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat Kreuzer, Peter M. Baghai, Thomas C. Rupprecht, Rainer Wittmann, Markus Steffling, Dagmar Ziereis, Michael Zowe, Marc Hausner, Helmut Langguth, Berthold Front Psychiatry Psychiatry The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are extremely present both for individuals and societies as a whole. In this manuscript, we aim to exemplarily describe the bullet points concerning (a) the internal risk management, (b) the organizational and structural changes, and (c) the communicational strategies applied in a Psychiatric University Hospital in the Southern part of Germany. The authors are well aware about the fact that almost none of these considerations may be considered as evidence-based at the moment. However, the authors trust that these reflections and experiences may be useful as an orientation for similar risk constellations in other afflicted countries due to the temporal delay of the pandemic course. Frontiers Media S.A. 2020-06-11 /pmc/articles/PMC7300317/ /pubmed/32595541 http://dx.doi.org/10.3389/fpsyt.2020.00550 Text en Copyright © 2020 Kreuzer, Baghai, Rupprecht, Wittmann, Steffling, Ziereis, Zowe, Hausner and Langguth http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Kreuzer, Peter M. Baghai, Thomas C. Rupprecht, Rainer Wittmann, Markus Steffling, Dagmar Ziereis, Michael Zowe, Marc Hausner, Helmut Langguth, Berthold SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
title | SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
title_full | SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
title_fullStr | SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
title_full_unstemmed | SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
title_short | SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat |
title_sort | sars-cov-2 risk management in clinical psychiatry: a few considerations on how to deal with an unrivaled threat |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300317/ https://www.ncbi.nlm.nih.gov/pubmed/32595541 http://dx.doi.org/10.3389/fpsyt.2020.00550 |
work_keys_str_mv | AT kreuzerpeterm sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT baghaithomasc sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT rupprechtrainer sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT wittmannmarkus sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT stefflingdagmar sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT ziereismichael sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT zowemarc sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT hausnerhelmut sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat AT langguthberthold sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat |